美国国立综合癌症网络（NCCN）指南见解：甲状腺癌，2025年第1版

NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025.

作者信息

Haddad Robert I, Bischoff Lindsay, Applewhite Megan, Bernet Victor, Blomain Erik, Brito Maria, Busaidy Naifa Lamki, Campbell Michael, DeLozier Olivia, Duh Quan-Yang, Ehya Hormoz, Grady Erin, Guo Theresa, Haymart Megan, Hunt Jason P, Kandeel Fouad, Kotwal Anupam, Lamonica Dominick M, Lorch Jochen, Mandel Susan J, Markovina Stephanie, Mydlarz Wojciech, Nabell Lisle, Raeburn Christopher D, Rezaee Rod, Ridge John A, Ritter Hadley, Roth Mara Y, Salgado Sarimar Agosto, Scheri Randall P, Shah Jatin P, Sipos Jennifer A, Sippel Rebecca, Sturgeon Cord, Wirth Lori J, Wong Richard J, Worden Francis, Yeh Michael W, Darlow Susan, Cassara Carly J, Sliker Bailee

机构信息

1Dana-Farber/Brigham and Women's Cancer Center | Mass General Cancer Center.

2Vanderbilt-Ingram Cancer Center.

出版信息

J Natl Compr Canc Netw. 2025 Jul;23(7). doi: 10.6004/jnccn.2025.0033.

DOI:10.6004/jnccn.2025.0033

PMID:40639400

Abstract

The NCCN Guidelines for Thyroid Carcinoma address the management of different types of thyroid carcinoma, including papillary, follicular, oncocytic, medullary, and anaplastic carcinoma. The NCCN Thyroid Carcinoma Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights focus on the panel's most recent recommendations regarding systemic therapies for thyroid carcinoma as well as the supporting clinical data.

摘要

美国国立综合癌症网络（NCCN）甲状腺癌临床实践指南涉及不同类型甲状腺癌的管理，包括乳头状癌、滤泡状癌、嗜酸细胞癌、髓样癌和未分化癌。NCCN甲状腺癌专家组至少每年召开一次会议，以审查来自其所在机构评审人员的意见，研究来自出版物和摘要的相关新数据，并重新评估和更新其建议。这些NCCN指南见解聚焦于专家组关于甲状腺癌全身治疗的最新建议以及支持性临床数据。